tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eliana Merle, 69 are a BUY (79.31%), 18 are a HOLD (20.69%).
Analyst Eliana Merle works at UBS with a stock forecast success ratio of 45.08% fulfilled within 173.95 days on average.
Eliana Merle’s has documented 186 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KOD, Kodiak Sciences at 04-Apr-2024.
Analyst best performing recommendations are on ANAB (ANAPTYSBIO).
The best stock recommendation documented was for ANAB (ANAPTYSBIO) at 11/7/2019. The price target of $28 was fulfilled within 1 day with a profit of $8.16 (22.57%) receiving and performance score of 225.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
57
$7.07 (14.16%)
67
8 days ago
14/17 (82.35%)
$8.97 (18.68%)
125
Buy
92
$42.07 (84.26%)
92
10 days ago
3/14 (21.43%)
$40.5 (78.64%)
108
Hold
60
$10.07 (20.17%)
60
29 days ago
2/4 (50%)
$1.51 (2.58%)
15
Buy
89
$39.07 (78.25%)
64
1 months 21 days ago
5/6 (83.33%)
$24.37 (37.71%)
391
Buy
79
$29.07 (58.22%)
75
2 months 26 days ago
6/10 (60%)
$13.03 (19.75%)
383
Which stock is Eliana Merle is most bullish on?
Which stock is Eliana Merle is most reserved on?
What Year was the first public recommendation made by Eliana Merle?
